GlassScriptPhysician profile
Lukasz Chebes
NPI 1689878878
$4,080.78
in general payments reported to CMS, 2019-2025
21 companies · $535 in 2025
The $535 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $150 · 2021: $478 · 2022: $688 · 2023: $828 · 2024: $1,016 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,379.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,695.30 | 2019-2025 | General - Pain Management, General - Therapies |
| Medtronic, INC. | $530.11 | 2021-2023 | Intellis Adaptivestim, Accurian |
| Averitas Pharma INC. | $407.46 | 2023-2025 | Qutenza |
| Medtronic USA, INC. | $301.36 | 2019-2020 | |
| Abbott Laboratories | $278.37 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $221.59 | 2022-2025 | Iovera, Zilretta |
| Biotronik Nro, INC. | $213.35 | 2023-2024 | Prospera, Biotronik |
| Biodelivery Sciences International, INC. | $61.09 | 2020-2021 | |
| Abbvie INC. | $57.79 | 2024 | |
| Spr Therapeutics, INC | $53.58 | 2024-2025 | Sprint Pns System |
| Stryker Corporation | $37.05 | 2022 | |
| Pacira Therapeutics, INC. | $36.47 | 2021 | |
| Foundation Fusion Solutions, LLC | $32.80 | 2021-2022 | |
| Avanos Medical | $32.00 | 2020-2023 | Genvisc 850 Sodium Hyaluronate |
| Bioventus LLC | $27.06 | 2024 | Stimrouter Implantable Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $22.78 | 2023 | |
| Terumo Bct, INC. | $19.69 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.16 | 2019 | |
| Collegium Pharmaceutical, INC. | $14.90 | 2019 | |
| Novus Surgical Consultants | $13.33 | 2022 | |
| Relievant Medsystems, INC. | $7.54 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lukasz Chebes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.